Tuesday, August 12, 2014

Top 10 Mid Cap Companies To Watch For 2014

Yesterday around midday,�Netherlands based aviation leasing stock�AerCap Holdings N.V. (NYSE: AER) began surging on rumors and closed up 11.6%, meaning its probably time to take a closer look at those rumors along with aviation leasing peers like small caps or mid caps�Aircastle Limited (NYSE: AYR), Air Lease Corp (NYSE: AL), Fly Leasing Ltd (NYSE: FLY) and AeroCentury Corp (NYSEMKT: ACY).

What is AerCap Holdings N.V.?

Headquartered in the Netherlands and with offices in Ireland, the United States, China, Singapore and the United Arab Emirates, AerCap Holdings N.V. is a�global leader in aircraft leasing and aviation finance with�$15 billion of assets that is funded by a ��obust long-term��capital structure producing ��ndustry-leading profitability.��AerCap Holdings N.V.�� fleet�also consists of modern fuel-efficient aircraft and is�one of the largest in the world.

Top 10 Freight Companies To Watch In Right Now: Concur Technologies Inc.(CNQR)

Concur Technologies, Inc. provides integrated travel and expense management solutions for companies of various industries, sizes, and geographies. It offers the Concur Connect platform, a cloud computing software solution primarily on a subscription basis, which enables customers, partners, suppliers, and third-party developers to connect. The company provides various solutions to streamline the travel procurement, itinerary management, expense management, and invoice management processes. Its solutions include online travel procurement solutions, which automate corporate travel booking and processing; itinerary management solutions that enable individual business travelers and their organizations to manage and share travel itinerary information; and automated expense management solutions, which simplify the expense reporting process. The company also offers other value-added and extended services that leverage its integrated cloud offerings, including expense reimbursemen t; expense report auditing services to streamline the process of managing and substantiating expense receipts; business intelligence that enable customers to use captured data to analyze trends, influence budget decisions, improve forecasting, and monitor for fraudulent activity; and invoice management solutions to automate, simplify, and reduce the costs associated with the process of entering, approving, and managing the payment of vendor invoices. In addition, it provides consulting; and various extended services, such as site administration, audit and compliance services, advanced analytics, and customized integration in connection with its integrated travel and expense management solutions. Concur markets and sells its solutions worldwide through direct sales organizations; and indirect distribution channels, such as strategic resellers and referral partners, as well as through its Website. The company was founded in 1993 and is headquartered in Redmond, Washington.

Advisors' Opinion:
  • [By Matt Jarzemsky]

    Salesforce is up 33% year-to-date. Workday Inc.(WDAY) has rallied 38% and expense-accounting software provider Concur Technologies(CNQR) is up 44%, to name a few.

  • [By Lee Jackson]

    The Lazard trading desk said that active traders may want to look at software stocks that still had unusually high short interest. Those included Concur Technologies (NASDAQ: CNQR), Tangoe Inc. (NASDAQ: TNGO), Jive Software (NASDAQ: JIVE), Marketo Inc. (NASDAQ: MKTO), VeriSign Inc. (NASDAQ: VRSN) and VMware Inc. (NYSE: VMW). Stocks with high short interest can explode to the upside if the company gets back on track and short sellers are forced to cover.

Top 10 Mid Cap Companies To Watch For 2014: Liberte Investors Inc. (FAC)

First Acceptance Corporation, through its subsidiaries, engages in retailing, servicing, and underwriting non-standard personal automobile insurance and related products. Its primary business involves issuing automobile insurance policies to individuals who are categorized as non-standard based primarily on their inability or unwillingness to obtain insurance coverage from standard carriers due to various factors, including their payment history or need for monthly payment plans, and failure to maintain continuous insurance coverage or driving record. The company also offers optional products that provide ancillary reimbursements and benefits in the event of an automobile accident; and underwrites a tenant homeowner policy that provides contents and liability coverage to renters. In addition, it engages in activities related to the disposition of real estate held for sale. The company distributes its products through retail locations. As of March 31, 2012, it leased and op erated 378 retail locations. First Acceptance Corporation was founded in 1969 and is based in Nashville, Tennessee.

Advisors' Opinion:
  • [By John Udovich]

    Auto sales continue to rise and that is good news for small cap auto insurers Infinity Property and Casualty Corp (NASDAQ: IPCC), First Acceptance Corporation (NYSE: FAC) and Atlas Financial Holdings Inc (NASDAQ: AFH) which are focused on niche auto insurance markets.�A Yahoo! Autos blog post�recently noted that in August, automakers sold 1.5 million new vehicles for the highest rate in years. Moreover,�most industry forecasters expect sales to�return to the level they hit before the 2008 recession of 16 million vehicles a year. The blog post then went on to note the three forces driving auto sales:

Top 10 Mid Cap Companies To Watch For 2014: ASML Holding N.V. (ASML)

ASML Holding N.V., through its subsidiaries, engages in designing, manufacturing, marketing, and servicing semiconductor processing equipment used in the fabrication of integrated circuits. The company offers a portfolio of lithography systems for manufacturing semiconductors, integrated circuits, or chips. It primarily provides PAS 5500 product family that comprises wafer steppers, and step and scan systems suitable for the i-line, krypton fluoride, and argon fluoride processing of wafers; TWINSCAN for manufacturing environments for which design resolutions down to 38 nanometers are required; TWINSCAN NXT system to support extreme ultraviolet lithography (EUV) imaging in various system critical areas; and NXE (EUV) system that utilizes reflective mirrors with a numerical aperture of 0.25. The company operates principally in Japan, Korea, Singapore, Taiwan, rest of Asia, Europe, and the United States. The company was formerly known as ASM Lithography Holding N.V. and chang ed its name to ASML Holding N.V. in 2001. ASML Holding N.V. was founded in 1984 and is headquartered in Veldhoven, the Netherlands.

Advisors' Opinion:
  • [By Ben Axler]

    We also note there has been a healthy pace of M&A consolidation in the semiconductor capital equipment industry in the past few years. For example, ASML Holdings (ASML) recently acquired Cymer and Tokyo Electron Ltd. (TYO: 8038) acquired FSI International. Lastly, we noted previously that Applied Materials (AMAT) acquired Varian Semiconductor in 2011, a close competitor to Axcelis. Our analysis suggests that the minimum valuation for a company in the industry is 1.2x, 11.0x and 2.2x revenues, EPS, and tangible book value, respectively. Furthermore, the average premium paid to the stock price has been a minimum of 35%.

  • [By Corinne Gretler]

    ASML Holding NV (ASML) climbed 2.5 percent to 52.55 euros. Europe�� largest semiconductor-equipment supplier posted first- quarter sales of 892 million euros, topping the 874 million-euro analyst estimate. The company also announced a share buyback program of as much as 1 billion euros and said Chief Executive Officer Eric Meurice will step down as of July.

Top 10 Mid Cap Companies To Watch For 2014: Standard Parking Corporation(STAN)

Standard Parking Corporation provides parking management, ground transportation, and other ancillary services to commercial, institutional, and municipal clients in the United States and Canada. Its services include collection and deposit of parking revenues; daily housekeeping; restriping of the parking stalls; maintenance of parking equipment, such as ticket dispensing machines, parking gate arms, and fee computers; painting of walkways, curbs, ceilings, walls, and other facility surfaces; and snow removal from sidewalks and driveways. The company also provides shuttle bus vehicles and drivers to operate them in support of on-airport car rental operations, as well as private off-airport parking locations; and ancillary ground transportation services at airports, such as taxi and livery dispatch, concierge-type ground transportation information, and support services for arriving passengers. In addition, it offers shuttle bus services, on-street parking meter collection, a nd other parking enforcement services for municipalities; and valet parking and shuttle bus services for the medical center and hospital markets. The company serves private and public owners, municipalities, managers and developers of office buildings, residential properties, commercial properties, shopping centers and other retail properties, sports and special event complexes, hotels, and hospitals and medical centers. As of December 31, 2011, it managed approximately 2,200 parking facility locations containing approximately 1.2 million parking spaces in approximately 345 cities; operated 147 parking-related service centers serving 61 airports; and a fleet of approximately 550 shuttle buses. The company was founded in 1929 and is headquartered in Chicago, Illinois.

Advisors' Opinion:
  • [By Namitha Jagadeesh]

    Elekta AB dropped 4.3 percent after posting quarterly profit that missed forecasts. Standard Chartered (STAN) Plc slid 6.6 percent. PSA Peugeot Citroen advanced 2.4 percent as Goldman Sachs Group Inc. added the shares to its conviction-buy list.

  • [By Namitha Jagadeesh]

    A gauge of banking shares in the FTSE 350 Index reversed earlier gains, declining 0.5 percent. Standard Chartered Plc (STAN) fell 1.8 percent to 1,470 pence and Royal Bank of Scotland Group Plc lost 2.6 percent to 276.7 pence.

Top 10 Mid Cap Companies To Watch For 2014: Norfolk Souther Corporation(NSC)

Norfolk Southern Corporation, through its subsidiaries, engages in the rail transportation of raw materials, intermediate products, and finished goods primarily in the United States. The company transports coal products, such as coal, coke, and iron ore; automotive products, including finished vehicles and auto parts; chemicals products consisting of sulfur and related chemicals, petroleum products, chlorine and bleaching compounds, plastics, rubber, industrial chemicals, chemical wastes, and municipal wastes; metals and construction products comprising steel, aluminum products, machinery, scrap metals, cement, aggregates, bricks, and minerals; and paper, clay, and forest products, including lumber and wood products, pulp board and paper products, wood fibers, wood pulp, scrap paper, and clay. It also transports agriculture, consumer, and government products, such as soybeans, wheat, corn, fertilizer, animal and poultry feed, food oils, flour, beverages, canned goods, swee teners, consumer products, ethanol, and items for the military. In addition, it engages in the intermodal operations that include moving of shipments in trailers, the United States and international containers, and roadrailer equipment. Further, the company transports overseas freight through various Atlantic and Gulf Coast ports, as well as provides a range of logistics services; and operates passenger and commuter trains. Additionally, it involves in the acquisition, leasing, and management of coal, oil, gas, and minerals; the development of commercial real estate; telecommunications; and the leasing or sale of rail property and equipment. As of December 31, 2010, the company operated approximately 20,000 route miles in 22 states and the District of Columbia. The company was founded in 1883 and is based in Norfolk, Virginia.

Advisors' Opinion:
  • [By Chad Fraser]

    Railroad stocks are the other angle: Norfolk Southern (NYSE: NSC), for example, has been focusing on boosting its intermodal traffic. In 2012, it generated $2.24 billion, or about 20% of its revenue, by shipping the versatile containers, up 5% from 2011.

Top 10 Mid Cap Companies To Watch For 2014: Genomic Health Inc (GHDX)

Genomic Health, Inc. (Genomic Health), incorporated in August 2000, is a molecular diagnostics company focused on the global development and commercialization of genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions. Its Oncotype DX platform utilizes quantitative genomic analysis known as reverse transcription polymerase chain reaction (RT-PCR), in standard tumor pathology specimens to provide tumor-specific information, or the oncotype of a tumor. As of February 2012, Oncotype DX was evaluated in invasive breast cancer in 13 clinical studies involving more than 4,000 breast cancer patients worldwide. Genomic Health offers its Oncotype DX tests as a clinical service, where it analyzes the expression levels of genes in tumor tissue samples and provide physicians with a quantitative gene expression profile expressed as a single quantitative score, which it calls a Recurrence Score, for invasive breast cancer and colon cancer and a DCIS Score for DCIS. Its Oncotype DX breast cancer test analyzes the expression levels of 21 genes and Oncotype DX colon cancer test analyzes the expression levels of 12 genes. In March 2012, the Company established a wholly owned subsidiary, InVitae Corporation.

Oncotype DX Platform

The Company�� Oncotype DX platform uses its RT-PCR approach to improve cancer treatment decisions. Its diagnostic approach correlates gene expression to clinical outcomes and provides an individualized analysis of each patient's tumor. The Company has built a diagnostic infrastructure that allows it to move from research into development through to processing actual patient samples in its clinical reference laboratory. The Company offers Oncotype DX tests as clinical laboratory services. Its technology allows the Company to analyze tumor tissue samples in its clinical reference laboratory and provide physicians with genomic information specific to the patient'! s tumor. It analyzes tissues that are handled, processed and stored under routine clinical pathology laboratory practices.

Oncotype DX Breast Cancer Test

To develop its Oncotype DX breast cancer test, the Company evaluated 250 genes in three independent clinical studies, which identified a 21-gene panel whose composite gene expression profile can be represented by a breast cancer Recurrence Score. The Company conducted studies of its Oncotype DX breast cancer test with clinical samples from postmenopausal women with invasive breast cancer who were treated with aromatase inhibitors. In March 2010, the Journal of Clinical Oncology published results from a European study using its test to analyze tumor samples from over 1,200 patients in the ATAC (Arimedix, Tamoxifen, Alone or in Combination) trial, which established the use of aromatase inhibitors for adjuvant treatment of postmenopausal women with hormone receptor-positive breast cancer. The study demonstrated that, along with other standard measures, such as tumor size, its Oncotype DX breast cancer test contributes independently to provide a more complete picture of prognosis for N- and N+ patients treated with aromatase inhibitors.

In December 2011, the Company presented positive results from the ECOG E5194 DCIS clinical validation study at SABCS. The study met its primary endpoint by demonstrating that a pre-specified Oncotype DX DCIS Score can predict the risk of local recurrence, defined as either the development of a new invasive breast cancer or the recurrence of DCIS in the same breast. In December 2011, the Company made Oncotype DX available for patients with ductal carcinoma in situ (DCIS), of the breast, a pre-invasive form of breast cancer. The launch of Oncotype DX for DCIS patients was based on positive results presented from a clinical validation study of Oncotype DX breast cancer test in patients with DCIS, conducted by the Eastern Cooperative Oncology Group (ECOG), a clinical trials cooperative! group su! pported by the National Cancer Institute.

Oncotype DX Colon Cancer Test

The Company developed its gene panel by identifying 761 cancer-related genes through review of existing research literature and computer analysis of genomic databases. The 761 candidate genes were also examined to determine whether they would be useful beyond other key variables including tumor stage, tumor grade, lymph nodes examined and MMR/MSI. It selected a final set of 12 genes, which were then independently evaluated in a validation study of over 1,400 stage II colon cancer patients from the Quick and Simple and Reliable (QUASAR), randomized study of adjuvant chemotherapy in the United Kingdom. This international, multi-center randomized trial examined the recurrence risk and the benefit associated with 5-fluorouracil/leucovorin, or 5FU/LV, adjuvant chemotherapy. Gene expression was quantified by RT-PCR from manually microdissected FPE primary colon cancer tissue, and recurrence-free interval, disease-free survival and overall survival were analyzed. In January 2012, the Company presented positive results of the first clinical decision making study of the Oncotype DX colon cancer test that shows that Recurrence Score result has a significant impact on treatment recommendations for stage II colon cancer patients.

The Company competes with General Electric Company, Hologic, Inc., Novartis AG, Myriad Genetics, Inc., Qiagen N.V., Response Genetics, Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Roche Holding, Ltd, Siemens AG and Johnson & Johnson.

Advisors' Opinion:
  • [By Keith Speights]

    Genetic testing stands out as one current example of how scientific advances can help reduce medical costs. Genomic Health (NASDAQ: GHDX  ) makes genetic diagnostic tests for�breast, colon, and prostate cancer. Half of the patients diagnosed with prostate cancer each year actually have a very low risk of the cancer progressing. However, 90% of these low-risk patients still undergo surgery or radiation -- at a cost of tens of thousands of dollars per patient. Genomic Health's genetic test helps identify which patients really need more extensive treatment and holds the potential to reduce overall costs.

Top 10 Mid Cap Companies To Watch For 2014: Infoblox Inc (BLOX)

Infoblox Inc. (Infoblox), incorporated in May 2003, is an automated network controller. The Company�� network functions include Internet protocol (IP) address management, device configuration, compliance, network discovery, policy implementation, security and monitoring. The Company�� appliance-based solution combines real-time IP address management with the automation of key network control and network change and configuration management processes in purpose-built physical and virtual appliances. It is based on its software that is scalable and automates vital network functions, such as IP address management, device configuration, compliance, network discovery, policy implementation, security and monitoring. It offers two families of products: Trinzic Enterprise and Trinzic NetMRI. The Trinzic Enterprise product family enables real-time IP address management and automates key network control processes. The Trinzic NetMRI product family automates network change and configuration management processes.

Trinzic Enterprise Family

The Company derives its product revenue from its Trinzic Enterprise family of products. The components of its Trinzic Enterprise family, are Trinzic Enterprise, Trinzic IPAM for Microsoft, Trinzic Reporting and Trinzic IPAM Insight. Its Trinzic Enterprise product is an appliance that is designed to for continuous operation of network control. Trinzic Enterprise offers file delivery services via the File Transfer Protocol (FTP), Trivial File Transfer Protocol (TFTP), and Hypertext Transfer Protocol (HTTP), time synchronization services via the Network Time Protocol (NTP) and Logging services via Syslog.

Trinzic IPAM for Microsoft provides a single, Web-based management interface for the centralized management of DNS, DHCP and multiple IP address pools running on Microsoft servers without any installation of software on Microsoft servers. It also provides Microsoft server management capabilities, such as centralized IP address management! , DNS changes and individualized, role-based access control. Trinzic Reporting provides long-term reporting, trending, analysis and tracking capabilities to report network utilization, isolate performance problems, implement DHCP and DNS capacity planning and identify security threats. Trinzic Reporting automates tasks associated with collecting, tabulating and correlating data and displays the information through its Web-based management interface. Trinzic IPAM Insight allows automated discovery of network device configuration information used in automation and compliance reporting.

Trinzic NetMRI Family

The Company�� Trinzic NetMRI products components of include Trinzic Network Automation, Trinzic Network Compliance, Trinzic Switch Port Manager and Trinzic PCI Insight. Its Trinzic NetMRI product automates network change and configuration management processes. Trinzic NetMRI enables information technology organizations to automate network changes, gain visibility into the impact of changes occurring on the network, manage network configurations, archive network configurations and meet a range of compliance requirements for both physical and virtual machines. Trinzic NetMRI discovers and monitors network infrastructure devices to determine critical network information. It uses this information to analyze network stability, to identify unauthorized devices and to take inventory of network devices for inventory management and/or troubleshooting. Trinzic Network Automation automates network configuration functions.

Trinzic Network Compliance automates the network compliance process, meeting corporate security requirements and providing the necessary information and control for internal and external compliance mandates. Trinzic Network Compliance also automatically alerts IT personnel in the event of a failure to meet compliance guidelines and permits the establishment and deployment of specific end customer requirements with click and drag simplicity, supporting ! complianc! e mandates such as those under the Payment Card Industry Data Security Standard (PCI DSS), the Health Insurance Portability and Accountability Act of 1996 (HIPAA), the Sarbanes-Oxley Act, Federal Energy Regulatory Commission (FERC) and North American Electric Reliability Corporation (NERC).

Trinzic Switch Port Manager enables its end customers to identify the number of switch ports, manage them precisely and locate the next available switch port. It helps provide views and management of switches with both current and historical IP addresses, MAC addresses, VLAN mappings and network device topology information. It also shows where devices have been connected, when they connected and where they are currently connected so that the network administrator can easily track authorized devices and find rogue devices that can pose security risks and create network instability. Trinzic PCI Insight is an integrated offering that bundles Trinzic Network Compliance, Trinzic IPAM Insight from its Trinzic Enterprise family of products and consulting services and enables its end customers to optimize their PCI DSS compliance.

The Company competes with BMC Software, Inc., EMC Corporation, Hewlett-Packard Company and International Business Machines Corporation, Alcatel-Lucent, BT Group plc and BlueCat Networks, Inc.

Advisors' Opinion:
  • [By Rich Bieglmeier]

    [Related -Infoblox Inc (BLOX): Getting off the Mat?]

    Infoblox is an automated network controller. The Company's network functions include Internet protocol (IP) address management, device configuration, compliance, network discovery, policy implementation, security and monitoring.

  • [By Jake L'Ecuyer]

    Equities Trading DOWN
    Shares of Infoblox (NYSE: BLOX) were down 47.01 percent to $17.59 after the company lowered its FY14 revenue forecast. Wedbush downgraded the stock from Outperform to Neutral and cut the price target from $36.00 to $25.00.

  • [By Lauren Pollock]

    Among the companies with shares expected to actively trade in Wednesday’s session are Hewlett-Packard Co.(HPQ), Infoblox Inc.(BLOX), and Tilly's Inc.(TLYS)

No comments:

Post a Comment